(Q40029733)

16 September 2017

title

The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study (English)

1 reference

16 September 2017

0 references

9

1 reference

16 September 2017

1

Ariel Graff-Guerrero

0 references

Ofer Agid

3

object named as

Ofer Agid

1 reference

16 September 2017

Romina Mizrahi

2

1 reference

16 September 2017

Heidi Marcon

4

1 reference

16 September 2017

Penny Barsoum

5

1 reference

16 September 2017

Pablo Rusjan

6

1 reference

16 September 2017

Alan A Wilson

7

1 reference

16 September 2017

Robert Zipursky

8

1 reference

16 September 2017

language of work or name

English

0 references

publication date

5 November 2008

1 reference

16 September 2017

number of pages

9

1 reference

inferred from page(s)

published in

Neuropsychopharmacology

1 reference

16 September 2017

volume

34

1 reference

16 September 2017

issue

4

1 reference

16 September 2017

page(s)

1078-1086

1 reference

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

Commentary and opinion: II. Statistical parametric mapping: ontology and current issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Presynaptic dopaminergic function in the striatum of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Dopamine D3 receptors expressed by all mesencephalic dopamine neurons

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Positron emission tomography quantification of [11C]-(+)-PHNO binding in the human brain.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Simplified reference tissue model for PET receptor studies.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

How dopamine dysregulation leads to psychotic symptoms? Abnormal mesolimbic and mesostriatal prediction error signalling in psychosis

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Measurement of the proportion of D2 receptors configured in state of high affinity for agonists in vivo: a positron emission tomography study using [11C]N-propyl-norapomorphine and [11C]raclopride in baboons

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Elevated dopa decarboxylase activity in living brain of patients with psychosis

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

An automated method for the extraction of regional data from PET images

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Dopamine D2(High) receptors on intact cells

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Dopamine receptors labelled by PHNO.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.199

7 January 2021

Identifiers

DOI

10.1038/NPP.2008.199

1 reference

Dimensions Publication ID

16 September 2017

1025925483

0 references

1 reference